Flagship Pioneering related stories
All articles and analysis
Blueprint Medicines Makes Chris Varma Permanent CEO; Names Daniel Lynch Executive ChairmanBlueprint Medicines, a Cambridge, Mass.-based company that's developing cancer therapies, has made Chris Varma, its founding president and an entrepreneur-in-residence at Third Rock Ventures, its permanent president and CEO. The company has also named Daniel Lynch as executive chairman of its board. Lynch spent nearly five years at ImClone Systems, including as CEO and CFO.
VCs See Rebirth in Life SciLife-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have raised or are raising funds this year in the $200 million to $400 million range dedicated to life sciences, biotech, and medicine...
- Fundraising Revives for Health Care VCs
Prospects look sunnier, as new funds are raised some healthy exits take place
- Venture Fundraising Roundup, February 2012
Updates on First Round, Vivo Ventures, Hyde Park and other VC firms
- Joule Inks $70M from Investors
Flagship Ventures, along with undisclosed investors, have poured $70 million into alternative fuel developer Joule. The company was formed in 2007 and is based in Bedford, Mass. The latest round brings Joule’s backing to more than $110 million. The latest round will be used to build out the company’s facility in Hobbs, New Mexico.